Subscribe to our weekly and daily Pearls and Irritations newsletter!
Most viewed recently
- MUNGO MacCALLUM. The Barnaby Joyce slapstick soap opera.
- PETER JOHNSTONE. Bishops in the headlights.
- MICHAEL PASCOE. Fear and loathing in superannuation – Liberal and industry fund conspiracy theories
- MUNGO MacCALLUM. The end of Western Civilisation!
- EMMA ALBERICI. There’s no case for a corporate tax cut when one in five of Australia’s top companies don’t pay it.
- PETER MANNING. Liberals on another planet 21 June 2018
- RICHARD BROINOWSKI. North Korea and the Trump Bashers 21 June 2018
- ALLAN PATIENCE: Our ABC! 21 June 2018
- RICHARD GLOVER. Move over, Emmanuel Macron. Australia has the true Trump whisperer. (Washington Post 19/6/2018) 21 June 2018
- 2018 Lowy Institute Poll – Climate change, renewables and coal. 21 June 2018
- Arts and Reviews (39)
- Defence/Security (783)
- Economy (1,036)
- Education (193)
- Environment and climate (309)
- Health (485)
- Housing (69)
- Human Rights (404)
- Indigenous affairs (59)
- Industrial relations (32)
- Infrastructure (151)
- International Affairs (1,455)
- Asia (157)
- Links (10)
- Media (494)
- NBN (73)
- Politics (2,357)
- Refugees, Immigration (528)
- Religion and Faith (475)
- SERIES: Freedom, opportunity and security (59)
- SERIES: Making housing affordable (15)
- Sport (51)
- Technology, start-ups and new media (1)
- Tributes (36)
- Uncategorized (163)
Tag Archives: pharmaceutical costs
In parliament, forty years ago on 27 September 1967, Gough Whitlam described the factors driving up the high cost of healthcare in Australia. The same vested interests drive up costs in Australia at the expense of the taxpayer and the … Continue reading
A low standard for granting patents can mean lengthy delays generic medicine availability. In one case this is shown to have cost taxpayers almost $A3 billion extra in Pharmaceutical Benefits Scheme outlays. A solution is to grant patents only for … Continue reading